Viewing nowCombinationAmlovaltaan Tablets 5/80 mg
Amlodipine Besylate 6.935mg · Valsartan 80mg
Tablet · Prescription medication · Combination
Shinpoong Pharmaceutical Co., Ltd.

MFDS item code 201308305 · Approved 2013.07.19 · Insurance code 648506990
Treatment of essential hypertension inadequately controlled with monotherapy
This medication is used for patients with essential hypertension whose blood pressure is not adequately controlled by monotherapy with amlodipine or valsartan.
The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended that the medicine be taken at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not controlled with monotherapy using an individual component as follows, switching directly to this medicine may be considered. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or higher). However, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients receiving dialysis. In patients with moderate renal impairment, monitoring of potassium levels and creatinine is recommended. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer this medicine to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Elderly patients aged 65 years or older: Use caution when increasing the dose.
The safety and efficacy of this medicine have not been established in pediatric patients under 18 years of age; therefore, its use is not recommended.
This medication may cause serious harm to the fetus and newborn when taken during the second and third trimesters of pregnancy, therefore women who are pregnant or may become pregnant should not take it. Patients with allergies to any of the ingredients in this medication or those with severe renal or liver dysfunction should not use this medication. Patients with sodium or fluid depletion should correct their condition before taking this medication, and if symptoms of hypotension occur during treatment, they should seek appropriate measures immediately. Patients with high potassium levels or those taking potassium supplements should have their potassium levels regularly checked. Patients with heart failure or post-myocardial infarction should closely monitor for changes in renal function while taking this medication, and those with acute myocardial infarction should carefully monitor for symptoms at the initiation of therapy. This medication may cause dizziness or fatigue when driving or operating machinery, so caution is necessary. This medication may interact with other drugs, especially those affecting blood pressure control or drugs like simvastatin and CYP3A4 inhibitors, so consultation with a doctor or pharmacist is advised when taking them together. It is recommended that women who are pregnant or breastfeeding do not take this medication, and should consult a doctor if planning to become pregnant. The safety and efficacy of this medication have not been sufficiently established in pediatric patients, and it is not recommended for use in this population. In case of overdose, severe hypotension or cardiac-related side effects may occur, hence the dosage should be strictly adhered to, and any abnormal symptoms should be reported to medical personnel immediately.
nasopharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, position-related dizziness, sensory disturbances, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, throat and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, hyperhidrosis, pruritus, joint swelling, low back pain, arthritis, muscle cramps, lethargy, urinary frequency, polyuria, erectile dysfunction, edema, local edema, facial edema, peripheral edema, fatigue, flushing, weakness, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, hyperkalemia, vasculitis, elevated liver function tests, angioedema, myalgia, renal failure, kidney damage, elevated serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, diplopia, thrombocytopenia, leukopenia, allergic reactions, hyperglycemia, insomnia, mood changes, tremors, sensory reduction, taste disorders, peripheral neuropathy, muscle hypertonicity, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urinary dysfunction, nocturia, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, elevated liver enzymes, chest discomfort, abdominal discomfort, gastroesophageal reflux disease, neck pain, hypercholesterolemia, hypoglycemia, neuroticism, Stevens-Johnson syndrome, chest pain, weight gain, arthralgia, skeletal pain, rhabdomyolysis, gingival hyperplasia, gastritis, sensory reduction
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture. The recommended storage temperature is between 1 to 30 degrees Celsius.
Dark yellow round film-coated tablet
30 tablets (10 tablets/PTP x 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationAmlodipine Besylate 6.935mg · Valsartan 80mg
Tablet · Prescription medication · Combination
Shinpoong Pharmaceutical Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandose Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.